The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Global burden of alcoholic liver diseases
Open accessAbstract
Liver diseases contribute markedly to the global burden of mortality and disease. This paper provides an overview from a global perspective of the contribution of alcohol to liver diseases. The Global Burden of Disease study methodology was used to estimate the burden of alcohol-attributable liver cirrhosis and alcohol-attributable liver cancer in 2010 as measured by deaths and disability adjusted life years (DALYs). This methodology estimates attributable fractions based on alcohol exposure distribution and relative risks associated with different levels of drinking. Globally, in 2010, alcohol-attributable liver cirrhosis was responsible for 493,300 deaths (156,900 female deaths and 336,400 male deaths) and 14,544,000 DALYs (4,112,000 DALYs for women and 10,432,000 DALYs for men), representing 0.9% (0.7% for women and 1.2% for men) of all global deaths and 0.6% (0.4% for women and 0.8% for men) of all global DALYs, and 47.9% of all liver cirrhosis deaths (46.5% for women and 48.5% for men) and 46.9% of all liver cirrhosis DALYs (44.5% for women and 47.9% for men). Alcohol-attributable liver cancer was responsible for 80,600 deaths (14,800 female deaths and 65,900 male deaths) and 2,142,000 DALYs (335,000 DALYs for women and 1,807,000 DALYs for men). The burden of alcohol-attributable liver cirrhosis and liver cancer is high and entirely preventable. Interventions to reduce alcohol consumption are recommended as a population health priority and may range from taxation increases for alcoholic beverages to increases in screening and treatment rates for alcohol use disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Liver disease is linked clearly to alcohol 277, evidenced by several ICD codes for alcoholic liver diseases (Table 1), including simple alcoholic steatosis, hepatitis, fibrosis and cirrhosis and superimposed hepatocellular carcinoma, which is part of alcohol‐attributable cancers (see above).”
From The relationship between different dimensions of alcohol use and the burden of disease—an update (2017) · cites this paper as [277]
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Murray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888
Global status report on noncommunicable diseases 2010.
Alwan, A. (2011) · Cited by 8,494
Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291
Ezzati, M., López, A. D., Rodgers, A., & Murray, C. J. L. (2004) · Cited by 3,319
Global Burden of Disease and Risk Factors
López, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T. T., & Murray, C. J. L. (2006) · World Bank, Washington, DC eBooks · doi:10.1596/978-0-8213-6262-4 · Cited by 2,714
Alcohol: No Ordinary Commodity. Research and public policy
Babor, T. F., Caetano, R., Casswell, S., Edwards, G., Giesbrecht, N., Graham, K., Grube, J. W., Hill, L., Holder, H. D., Homel, R. J., et al. (2003) · Cited by 1,718
Self-citationUse and misuse of population attributable fractions
Rockhill, B., Newman, B., & Weinberg, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.1.15 · Cited by 1,683
Nonalcoholic fatty liver disease
Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045232 · Cited by 1,658
Flagged first, then by citations
Research works printed but not linked: 1
- Kehoe, 2012, Determining the best population-level alcohol consumption model and its impact on estimates of alcohol-attributable harms, Popul Health Metrics, 10, 6, 10.1186/1478-7954-10-6 · DOI · Paper page
Cited by
Sorted by citations
Items 101–200 of 738
Gut microbiota and systemic immunity in health and disease
Lo, B. C., Chen, G., Núñez, G., & Caruso, R. (2020) · International Immunology · doi:10.1093/intimm/dxaa079 · Cited by 90
Hepatoprotective effects of garlic against ethanol-induced liver injury: A mini-review
Guan, M.-J., Zhao, N., Xie, K., & Zeng, T. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.11.059 · Cited by 87
Gao, Y., Chu, S., Li, J., Li, J., Zhang, Z., Xia, C., Heng, Y., Zhang, M., Hu, J., Wei, G., et al. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.07.020 · Cited by 86
Systematic review: unmet supportive care needs in people diagnosed with chronic liver disease
Valery, P. C., Powell, E. E., Moses, N., Volk, M. L., McPhail, S., Clark, P. J., & Martin, J. H. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-007451 · Cited by 85
LncRNA NEAT1/microRNA-129-5p/SOCS2 axis regulates liver fibrosis in alcoholic steatohepatitis
Ye, J., Lin, Y., Yu, Y., & Sun, D. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02577-5 · Cited by 85
Wang, X., Luo, J., Chen, R., Zha, X., & Pan, L. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.04.024 · Cited by 84
Nutrition in Cirrhosis and Chronic Liver Disease
Juakiem, W. Y., Torres, D. M., & Harrison, S. A. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.09.004 · Cited by 83
Zhao, Y., Lü, J., Mao, A., Zhang, R., & Guan, S. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c03751 · Cited by 81
PNPLA3 expression and its impact on the liver: current perspectives
Bruschi, F. V., Tardelli, M., Claudel, T., & Trauner, M. (2017) · Hepatic Medicine: Evidence and Research · doi:10.2147/hmer.s125718 · Cited by 81
Nasr, P., Wester, A., Ekstedt, M., Strandberg, R., Kechagias, S., Shang, Y., Widman, L., & Hagström, H. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.01.006 · Cited by 80
Alavi, M., Janjua, N. Z., Chong, M., Grebely, J., Aspinall, E., Innes, H. A., Valerio, H., Hajarizadeh, B., Hayes, P. C., Krajden, M., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.10.019 · Cited by 80
PCSK9 inhibition as a novel therapeutic target for alcoholic liver disease
Lee, J. S., Mukhopadhyay, P., Mátyás, C., Trojnár, E., Pálóczi, J., Yang, Y. R., Blank, B. A., Savage, C. H., Sorokin, A. V., Mehta, N. N., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-53603-6 · Cited by 79
Diagnosis and Management of Alcoholic Liver Disease
Dugum, M. F., & McCullough, A. J. (2015) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2015.00008 · Cited by 79
Dynamic Changes of the Fungal Microbiome in Alcohol Use Disorder
Hartmann, P., Lang, S., Zeng, S.-L., Duan, Y., Zhang, X., Wang, Y., Bondareva, M. A., Kruglov, A., Fouts, D. E., Stärkel, P., et al. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.699253 · Cited by 78
Cancer prevention and control: alarming challenges in China
Bode, A. M., Dong, Z., & Wang, H. (2016) · National Science Review · doi:10.1093/nsr/nwv054 · Cited by 78
CRIg on liver macrophages clears pathobionts and protects against alcoholic liver disease
Duan, Y., Chu, H., Brandl, K., Jiang, L., Zeng, S.-L., Meshgin, N., Papachristoforou, E., Argemí, J., Mendes, B. G., Wang, Y., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27385-3 · Cited by 81
Sangineto, M., Grander, C., Grabherr, F., Mayr, L., Enrich, B., Schwärzler, J., Dallio, M., Bukke, V. N., Moola, A., Moschetta, A., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2089006 · Cited by 77
Saha, B., Tornai, D., Kodys, K., Adejumo, A., Lowe, P., McClain, C. J., Mitchell, M. C., McCullough, A. J., Dasarathy, S., Kroll‐Desrosiers, A., et al. (2019) · Hepatology · doi:10.1002/hep.30617 · Cited by 75
Alcoholic liver disease: Treatment
Suk, K. T. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i36.12934 · Cited by 74
Key Events Participating in the Pathogenesis of Alcoholic Liver Disease
Magdaleno, F., Blajszczak, C. C., & Nieto, N. (2017) · Biomolecules · doi:10.3390/biom7010009 · Cited by 75
Alcoholic and Nonalcoholic Fatty Liver Disease and Liver-Related Mortality: A Cohort Study
Chang, Y., Cho, Y. K., Cho, J., Jung, H.-S., Yun, K. E., Ahn, J., Sohn, C. I., Shin, H. C., & Ryu, S. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000074 · Cited by 74
Mitochondrial depolarization after acute ethanol treatment drives mitophagy in living mice
Samuvel, D. J., Li, L., Krishnasamy, Y., Gooz, M. B., Takemoto, K., Woster, P. M., Lemasters, J. J., & Zhong, Z. (2022) · Autophagy · doi:10.1080/15548627.2022.2046457 · Cited by 76
Kirpich, I., McClain, C. J., Vatsalya, V., Schwandt, M. L., Phillips, M. J., Falkner, K. C., Zhang, L., Harwell, C., George, D. T., & Umhau, J. C. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13346 · Cited by 74
Yang, Z., Kusumanchi, P., Ross, R. A., Heathers, L., Chandler, K., Oshodi, A., Thoudam, T., Li, F., Wang, L., & Liangpunsakul, S. (2019) · Hepatology Communications · doi:10.1002/hep4.1322 · Cited by 73
Xia, T., Zhang, B., Li, S., Fang, B., Duan, W., Zhang, J., Song, J. M., & Wang, M. (2020) · Food & Function · doi:10.1039/c9fo03015h · Cited by 71
Changes in the Epidemiology of Hepatocellular Carcinoma in Asia
Liu, Y., & Liu, L. (2022) · Cancers · doi:10.3390/cancers14184473 · Cited by 72
Jiang, X., Li, Y., Ye, J., Lv, L., Yang, L.-Y., Bian, X., Wu, W., Wu, J., Shi, D., Wang, Q., et al. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i40.6224 · Cited by 71
Treatment of Severe Alcoholic Hepatitis
Thursz, M. R., & Morgan, T. R. M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.074 · Cited by 70
Janani, G., Nandi, S. K., & Mandal, B. B. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.11.053 · Cited by 70
Doing it by numbers: A simple approach to reducing the harms of alcohol
Nutt, D., & Rehm, J. T. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881113512038 · Cited by 68
Self-citationRole of autophagy in alcohol and drug-induced liver injury
Williams, J. A. R., & Ding, W. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.111075 · Cited by 66
A Mechanistic Review of Mitophagy and Its Role in Protection against Alcoholic Liver Disease
Williams, J. A. R., & Ding, W. (2015) · Biomolecules · doi:10.3390/biom5042619 · Cited by 68
Litwinowicz, K., Choroszy, M., & Waszczuk, E. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2019.1669629 · Cited by 72
Preventive and therapeutic role of betaine in liver disease: A review on molecular mechanisms
Wang, C., Ma, C., Gong, L., Dai, S., & Li, Y. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174604 · Cited by 69
Atkinson, S. R., Way, M. J., McQuillin, A., Morgan, M. Y., & Thursz, M. R. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.018 · Cited by 66
Zhang, N., Hu, Y. W., Ding, C., Zeng, W., Shan, W., Fan, H. J., Zhao, Y., Shi, X., Gao, L., Xu, T., et al. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.12.010 · Cited by 64
Hollenbach, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112466 · Cited by 62
Silva, J., Spatz, M. H., Folk, C., Chang, A., Cadenas, E., Liang, J., & Davies, D. L. (2020) · Alcohol · doi:10.1016/j.alcohol.2020.10.002 · Cited by 62
Yang, W., Huang, L.-M., Gao, J., Wen, S., Tai, Y., Chen, M., Huang, Z., Liu, R., Tang, C., & Li, J. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7295 · Cited by 62
Chastain, L. G., & Sarkar, D. K. (2017) · Alcohol · doi:10.1016/j.alcohol.2016.12.007 · Cited by 66
Harman, D. J., Ryder, S. D., James, M. W., Wilkes, E., Card, T. R., Aithal, G. P., & Guha, I. N. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14463 · Cited by 61
Alcoholic Liver Disease: Current Mechanistic Aspects with Focus on Their Clinical Relevance
Teschke, R. (2019) · Biomedicines · doi:10.3390/biomedicines7030068 · Cited by 62
Naltrexone for alcohol use disorder: Hepatic safety in patients with and without liver disease
Ayyala-Somayajula, D., Bottyan, T., Tien, C., Pimienta, M., Yoo, J. C., Stager, K., González, J. L., Stolz, A., Dodge, J. L., Terrault, N. A., et al. (2022) · Hepatology Communications · doi:10.1002/hep4.2080 · Cited by 64
Acute kidney injury and hepatorenal syndrome in cirrhosis
Israelsen, M. E., Gluud, L., & Krag, A. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12709 · Cited by 72
Cots, M. V., Watts, A. E., Cruz-Lemini, M., Shah, N., Ndugga, N., McCann, P., Barritt, A. S., Jain, A., Ravi, S., Fernández‐Carrillo, C., et al. (2018) · Hepatology · doi:10.1002/hep.30315 · Cited by 60
Molecular mechanisms of psychiatric diseases
Blokhin, I. O., Khorkova, O., Saveanu, R. V., & Wahlestedt, C. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105136 · Cited by 64
Shi, Y., Liu, Y., Wang, S., Huang, J., Luo, Z., Jiang, M., Lu, Y., Lin, Q., Liu, H., Cheng, N., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121720 · Cited by 58
Chen, W.-Y., Zhang, J., Ghare, S. S., Barve, S. S., McClain, C. J., & Joshi‐Barve, S. (2016) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2016.05.010 · Cited by 57
Guo, Y., Cao, L., Zhao, Q., Zhang, L., Chen, J., Liu, B., & Zhao, B. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.09.039 · Cited by 57
Tan, X., Hong, J., Jiang, S., Zhang, S., Chen, Y., & Feng, G. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c02743 · Cited by 57
Lee, Y.-H., Kim, J.-H., Kim, S. H., Oh, J. H., Seo, W. D., Kim, K.-M., Jung, J., & Jung, Y.-S. (2016) · Nutrients · doi:10.3390/nu8070440 · Cited by 56
Tian, X., Li, R., Jiang, Y., Zhao, F., Yu, Z., Wang, Y., Dong, Z., Liu, P., & Li, X. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104045 · Cited by 55
Pathology of Alcoholic Liver Disease
Celli, R., & Zhang, X. (2014) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2014.00010 · Cited by 55
Zhong, Z., & Lemasters, J. J. (2018) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13877 · Cited by 58
Li, M., Wang, Z. Q., Zhang, L., Zheng, H., Liu, D. W., & Zhou, M. G. (2020) · PubMed · doi:10.3967/bes2020.001 · Cited by 53
Rehm, J. T., Patra, J., Brennan, A., Buckley, C. M., Greenfield, T. K., Kerr, W. C., Manthey, J., Purshouse, R. C., Rovira, P., Shuper, P. A., et al. (2021) · Drug and Alcohol Review · doi:10.1111/dar.13286 · Cited by 58
Self-citationThe Role of Vitamin Deficiency in Liver Disease: To Supplement or Not Supplement?
Licata, A., Zerbo, M. K., Como, S., Cammilleri, M., Soresi, M., Montalto, G., & Giannitrapani, L. (2021) · Nutrients · doi:10.3390/nu13114014 · Cited by 66
From intestinal dysbiosis to alcohol-associated liver disease
Mendes, B. G., & Schnabl, B. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0086 · Cited by 57
Thomas, R. G., Moon, M. J., Kim, J. H., Lee, J. H., & Jeong, Y. Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145512 · Cited by 53
Yang, Z., Ross, R. A., Zhao, S., Tu, W., Liangpunsakul, S., & Wang, L. (2017) · Hepatology Communications · doi:10.1002/hep4.1061 · Cited by 53
Xie, L., Yan, C., Zhao, Q., He, M., & Jiang, T.-A. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i9.957 · Cited by 53
Obesity in acute alcoholic hepatitis increases morbidity and mortality
Parker, R., Kim, S. J., Im, G. Y., Nahas, J., Dhesi, B., Vergis, N., Sinha, A., Ghezzi, A., Rink, M. R., McCune, A., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.03.046 · Cited by 53
Behavior of Oxidative Stress Markers in Alcoholic Liver Cirrhosis Patients
Galicia-Moreno, M., Rosique-Oramas, D., Medina-Avila, Z., Álvarez-Torres, T., Falcón, D., Higuera-de la tijera, F., Béjar, Y. L., Cordero-Pérez, P., Muñoz-Espinosa, L., Pérez-Hernández, J. L., et al. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9370565 · Cited by 52
de Ternay, J., Naassïla, M., Nourredine, M., Louvet, A., Bailly, F., Sescousse, G., Maurage, P., Cottencin, O., Carrieri, P., & Rolland, B. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00627 · Cited by 52
Mitochondria and the NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis
Torres, S., Segalés, P., García‐Ruiz, C., & Fernández-Checa, J. C. (2022) · Cells · doi:10.3390/cells11091475 · Cited by 51
Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
Rodrigues, S. G., der Merwe, V., Krag, A. A., & Wiest, R. (2024) · Seminars in Immunology · doi:10.1016/j.smim.2023.101859 · Cited by 51
Kim, M.-S. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i1.8 · Cited by 51
Gut microbial RNA and DNA analysis predicts hospitalizations in cirrhosis
Bajaj, J. S., Thacker, L. R., Fagan, A., White, M. B., Gavis, E. A., Hylemon, P. B., Brown, R. E., Acharya, C., Heuman, D. M., Fuchs, M. A., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.98019 · Cited by 51
Listenberger, L. L., Townsend, E., Rickertsen, C., Hains, A. E., Brown, E., Inwards, E. G., Stoeckman, A. K., Matis, M. P., Sampathkumar, R. S., Osna, N. A., et al. (2018) · Cells · doi:10.3390/cells7120230 · Cited by 49
Integrated Care of Alcohol-Related Liver Disease
Winder, G. S., Fernandez, A. C., & Mellinger, J. L. (2022) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2022.01.010 · Cited by 51
Askgaard, G., Leon, D. A., Kjær, M. S., Deleuran, T., Gerds, T. A., & Tolstrup, J. S. (2016) · Hepatology · doi:10.1002/hep.28943 · Cited by 49
Alkhouri, N., Almomani, A., Le, P., Payne, J. Y., Asaad, I., Sakkal, C., Vos, M. B., Noureddin, M., & Kumar, P. N. (2022) · BMC Gastroenterology · doi:10.1186/s12876-022-02430-7 · Cited by 48
Teschke, R. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1465929 · Cited by 48
NIK links inflammation to hepatic steatosis by suppressing PPARα in alcoholic liver disease
Li, Y., Chen, M., Zhou, Y., Tang, C., Zhang, W., Zhong, Y., Chen, Y., Zhou, H. Y., & Sheng, L. (2020) · Theranostics · doi:10.7150/thno.40149 · Cited by 48
Ha, Y., Jeong, I., & Kim, T. H. (2022) · Biomedicines · doi:10.3390/biomedicines10102530 · Cited by 47
Macrophage Signaling Pathways in Health and Disease: From Bench to Bedside Applications
Chi, Y., Jiang, H., Yin, Y., Zhou, X., Shao, Y., Li, Y., & Rao, J. (2025) · MedComm · doi:10.1002/mco2.70256 · Cited by 54
Guo, X., Cui, R., Zhao, J., Mo, R., Peng, L., & Yan, M. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.09.031 · Cited by 47
Mehta, G., Macdonald, S., Cronberg, A., Rosselli, M., Khera, T. T., Sumpter, C., Al-Khatib, S., Jain, A., Maurice, J. B., Charalambous, C., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-020673 · Cited by 46
Folic acid ameliorates alcohol-induced liver injury via gut–liver axis homeostasis
Zhang, H., Zuo, Y., Zhao, H., Zhao, H. J., Wang, Y., Zhang, X., Zhang, J., Wang, P., Sun, L., Zhang, H., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.989311 · Cited by 46
Alcohol Policies and Alcoholic Cirrhosis Mortality in the United States
Hadland, S. E., Xuan, Z., Blanchette, J. G., Heeren, T., Swahn, M. H., & Naimi, T. S. (2015) · Preventing Chronic Disease · doi:10.5888/pcd12.150200 · Cited by 45
Luginbühl, M., Weinmann, W., Butzke, I., & Pfeifer, P. (2019) · Drug Testing and Analysis · doi:10.1002/dta.2567 · Cited by 45
Alcohol-associated Cirrhosis and Alcoholic Hepatitis Hospitalization Trends in the United States
Shirazi, F., Singal, A. K., & Wong, R. J. (2020) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001378 · Cited by 45
The Gut–Liver Axis in Chronic Liver Disease: A Macrophage Perspective
Muynck, K. D., Vanderborght, B., Vlierberghe, H. V., & Devisscher, L. (2021) · Cells · doi:10.3390/cells10112959 · Cited by 48
Fang, H., Zhang, A., Sun, H. J., Yu, J., Wang, L., & Wang, X. (2019) · Journal of Chromatography B · doi:10.1016/j.jchromb.2019.01.017 · Cited by 44
Trends in Premature Deaths From Alcoholic Liver Disease in the U.S., 1999–2018
Yoon, Y., Chen, C. M., Slater, M. E., Jung, M. K., & White, A. M. (2020) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2020.04.024 · Cited by 46
Current understanding of the metabolism of micronutrients in chronic alcoholic liver disease
Wu, J., & Meng, Q. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i31.4567 · Cited by 44
Dong, H., Hao, L., Zhang, W., Zhong, W. H., Guo, W., Yue, R., Sun, X., & Zhou, Z. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.05.013 · Cited by 43
Malaekeh-Nikouei, A., Shokri-Naei, S., Foroushan, S. K., Bahari, H., Rahimi, V. B., Heidari, R., & Askari, V. R. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115263 · Cited by 46
Correnti, J., Juskeviciute, E., Swarup, A., & Hoek, J. B. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00395.2013 · Cited by 42
The role of immune mechanisms in alcoholic and nonalcoholic steatohepatitis: a 2015 update
Sutti, S., Bruzzì, S., & Albano, E. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1111758 · Cited by 40
Disease spectrum of alcoholic liver disease in Beijing 302 Hospital from 2002 to 2013
Huang, A., Chang, B., Sun, Y., Lin, H., Li, B., Teng, G., & Zou, Z. (2017) · Medicine · doi:10.1097/md.0000000000006163 · Cited by 42
Antimicrobial proteins: intestinal guards to protect against liver disease
Hendrikx, T., & Schnabl, B. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1521-8 · Cited by 42
Fang, T. J., Guo, J.-T., Lin, M., Lee, M., Chen, Y.-L., & Lin, W.-H. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-10122-8 · Cited by 42
Lechner, S., Yee, M. F., Limketkai, B. N., & Pham, E. A. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06100-0 · Cited by 42
Hagström, H., Thiele, M. S., Sharma, R., Simon, T. G., Roelstraete, B., Söderling, J. K., & Ludvigsson, J. F. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.01.005 · Cited by 41
Jung, J. H., Kim, S. E., Suk, K. T., & Kim, D. J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.913842 · Cited by 42
Sahlman, P., Nissinen, M. J., Pukkala, ., & Färkkilä, M. A. (2016) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2016.1157889 · Cited by 41
Nojkov, B. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i1.446 · Cited by 41
Hepatic Fibrosis and Cirrhosis
Rockey, D. C. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch105 · Cited by 41
Albertsen, A. (2020) · Political research quarterly · doi:10.1177/1065912919845077 · Cited by 24
Metadata
- Authors
- Rehm, J., Samokhvalov, A. V., & Shield, K. D.
- Affiliations
- Centre for Addiction and Mental Health (CA)
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 59
- Issue
- 1
- Pages
- 160-168
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2048180954
- Cited by
- 740
- References
- 59
- Citations by year
- 2026: 25 · 2025: 47 · 2024: 42 · 2023: 53 · 2022: 67 · 2021: 61 · 2020: 89 · 2019: 76 · 2018: 74 · 2017: 73 · 2016: 50 · 2015: 55 · 2014: 23 · 2013: 4
- FWCI
- 6.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Hepatology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Ontario Ministry of Health and Long-Term Care
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Global Public Health Policies and Epidemiology
- Keywords
- alcoholic liver disease, liver cirrhosis, liver cancer, disability-adjusted life years, alcohol consumption, attributable fraction, alcohol taxation, global burden of disease
- MeSH terms
- Alcohol Drinking, Female, Humans, Liver Cirrhosis, Alcoholic, Liver Diseases, Alcoholic, Liver Neoplasms, Male, Risk Factors, Sex Factors, Global Health, Quality-Adjusted Life Years
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
